Factorial Partners, LLC Astrazeneca PLC Transaction History

Factorial Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $110,580 - $124,470	-3,000 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$34.76 - $39.72 $104,280 - $119,160	3,000 New	3,000 $119 Million
Q2 2018 Aug 01, 2018	SELL	$34.55 - $37.05 $1.24 Million - $1.33 Million	-35,900 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$32.97 - $36.63 $115,395 - $128,205	3,500 Added 10.8%	35,900 $1.26 Billion
Q4 2017 Apr 19, 2018	BUY	$32.09 - $34.78 $1.04 Million - $1.13 Million	32,400	32,400 $1.12 Billion

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Factorial Partners, LLC with notifications on news.